BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24793938)

  • 1. B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial.
    Jahnmatz M; Amu S; Ljungman M; Wehlin L; Chiodi F; Mielcarek N; Locht C; Thorstensson R
    Vaccine; 2014 Jun; 32(27):3350-6. PubMed ID: 24793938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice.
    Feunou PF; Kammoun H; Debrie AS; Locht C
    Vaccine; 2014 Jul; 32(34):4281-8. PubMed ID: 24950361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers.
    Thorstensson R; Trollfors B; Al-Tawil N; Jahnmatz M; Bergström J; Ljungman M; Törner A; Wehlin L; Van Broekhoven A; Bosman F; Debrie AS; Mielcarek N; Locht C
    PLoS One; 2014; 9(1):e83449. PubMed ID: 24421886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1.
    Feunou PF; Kammoun H; Debrie AS; Mielcarek N; Locht C
    Vaccine; 2010 Oct; 28(43):7047-53. PubMed ID: 20708998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study.
    Jahnmatz M; Richert L; Al-Tawil N; Storsaeter J; Colin C; Bauduin C; Thalen M; Solovay K; Rubin K; Mielcarek N; Thorstensson R; Locht C;
    Lancet Infect Dis; 2020 Nov; 20(11):1290-1301. PubMed ID: 32687804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3.
    Debrie AS; Coutte L; Raze D; Mooi F; Alexander F; Gorringe A; Mielcarek N; Locht C
    Vaccine; 2018 Mar; 36(11):1345-1352. PubMed ID: 29433898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans.
    Lin A; Apostolovic D; Jahnmatz M; Liang F; Ols S; Tecleab T; Wu C; van Hage M; Solovay K; Rubin K; Locht C; Thorstensson R; Thalen M; Loré K
    J Clin Invest; 2020 May; 130(5):2332-2346. PubMed ID: 31945015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1.
    Feunou PF; Ismaili J; Debrie AS; Huot L; Hot D; Raze D; Lemoine Y; Locht C
    Vaccine; 2008 Oct; 26(45):5722-7. PubMed ID: 18762220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated Bordetella pertussis BPZE1 as a live vehicle for heterologous vaccine antigens delivery through the nasal route.
    Li R; Lim A; Alonso S
    Bioeng Bugs; 2011; 2(6):315-9. PubMed ID: 22067832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.
    Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM
    Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective role of adenylate cyclase in the context of a live pertussis vaccine candidate.
    Lim A; Ng JK; Locht C; Alonso S
    Microbes Infect; 2014 Jan; 16(1):51-60. PubMed ID: 24140230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection.
    Locht C; Papin JF; Lecher S; Debrie AS; Thalen M; Solovay K; Rubin K; Mielcarek N
    J Infect Dis; 2017 Jul; 216(1):117-124. PubMed ID: 28535276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice.
    Kammoun H; Feunou PF; Foligne B; Debrie AS; Raze D; Mielcarek N; Locht C
    Vaccine; 2012 Aug; 30(40):5864-70. PubMed ID: 22814407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model.
    Skerry CM; Mahon BP
    Clin Vaccine Immunol; 2011 Feb; 18(2):187-93. PubMed ID: 21147936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins.
    Hendrikx LH; Oztürk K; de Rond LG; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM
    Vaccine; 2011 Feb; 29(7):1431-7. PubMed ID: 21187178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of live, attenuated intranasal Bordetella pertussis vaccine (BPZE1) in healthy adults.
    Buddy Creech C; Jimenez-Truque N; Kown N; Sokolow K; Brady EJ; Yoder S; Solovay K; Rubin K; Noviello S; Hensel E; Selamawi S; Bakare A; Makowski M; Lu K
    Vaccine; 2022 Nov; 40(47):6740-6746. PubMed ID: 36220716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus-diphtheria-acellular pertussis vaccine: a randomised, double-blind, phase 2b trial.
    Keech C; Miller VE; Rizzardi B; Hoyle C; Pryor MJ; Ferrand J; Solovay K; Thalen M; Noviello S; Goldstein P; Gorringe A; Cavell B; He Q; Barkoff AM; Rubin K; Locht C
    Lancet; 2023 Mar; 401(10379):843-855. PubMed ID: 36906345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated Bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model.
    Kavanagh H; Noone C; Cahill E; English K; Locht C; Mahon BP
    Clin Exp Allergy; 2010 Jun; 40(6):933-41. PubMed ID: 20184606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Protection against Pertussis Induced by Live Attenuated
    Debrie AS; Mielcarek N; Lecher S; Roux X; Sirard JC; Locht C
    J Immunol; 2019 Dec; 203(12):3293-3300. PubMed ID: 31732529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice.
    Mielcarek N; Debrie AS; Mahieux S; Locht C
    Clin Vaccine Immunol; 2010 Mar; 17(3):317-24. PubMed ID: 20107007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.